文献速递腹部CT

CT 强化瘤内异质性用于混合型肝细胞癌-胆管癌成分预测及预后意义

Intratumoral heterogeneity of CT enhancement for component prediction and prognostic significance in combined hepatocellular carcinoma‑cholangiocarcinoma.
PubMed 文献 · Eur Radiol · 2025-10-02

该回顾性研究纳入 165 例经病理诊断的混合型肝细胞癌-胆管癌患者,基于 CT 早期和晚期强化率图用 k-means 聚类构建瘤内栖息地影像,联合影像特征建立列线图预测以肝细胞癌为主的成分;联合列线图在训练集和验证集 AUC 分别为 0.927 和 0.923,并可对无复发生存和总生存进行预后分层。

要点

  • 基于 CT 强化率图的栖息地影像可量化瘤内异质性,辅助预测 cHCC-CCA 主要成分。
  • 联合列线图整合栖息地参数与影像特征,训练集 AUC 0.927、验证集 AUC 0.923。
  • 列线图预测高 HCC 成分组无复发生存和总生存优于预测低 HCC 成分组。

核心结论

  • 基于强化的 CT 栖息地影像有潜力预测 cHCC-CCA 的主要成分,并为预后分层提供工具。

研究设计与样本

  • 回顾性纳入经病理诊断且接受增强 CT 检查的 cHCC-CCA 患者,随机分为训练队列和验证队列,最终纳入 165 例。
  • 按病理将肿瘤分为高肝细胞癌成分组(high-HCC%)和低肝细胞癌成分组(low-HCC%)。
  • 基于早期强化率图和晚期强化率图的肿瘤体素,通过 k-means 算法聚类为不同栖息地,并量化各栖息地的体积分数。

关键影像表现/征象

  • 高 HCC% 组的栖息地 1 分数(f1)显著高于低 HCC% 组,而栖息地 4 分数(f4)显著低于低 HCC% 组。
  • 肿瘤包膜、晕环强化、延迟强化、f1 和 f4 被用于构建联合列线图。

诊断标准与关键数值

  • 联合列线图预测主要成分的 AUC 在训练队列为 0.927,在验证队列为 0.923。
  • 列线图预测高 HCC% 组在无复发生存和总生存方面优于预测低 HCC% 组。

临床应用与阅片要点

  • 阅片时可关注肿瘤包膜、晕环强化和延迟强化等影像特征,并结合强化率图栖息地参数评估 cHCC-CCA 主要成分。
  • 基于栖息地的联合列线图可能为 cHCC-CCA 患者的个体化治疗提供参考工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To construct a combined nomogram using CT enhancement ratio-based habitat imaging and radiological features in predicting the main component of combined hepatocellular carcinoma‑cholangiocarcinoma (cHCC-CCA), and to assess its ability for stratifying the prognosis.

MATERIALS AND METHODS: Patients with pathologically diagnosed cHCC-CCA who underwent contrast-enhanced CT examinations were retrospectively included and randomized into the training and validation cohorts. Tumors were grouped into high hepatocellular carcinoma (HCC) component (high-HCC%) and low-HCC component (low-HCC%) according to pathology. Voxels of tumor from early enhancement ratio and late enhancement ratio maps were clustered into different habitats through the k-means algorithm. The volume fractions of different habitats were quantified. Logistic regression analyses were utilized to identify independent predictors for high-HCC%, construct prediction models, and visualize them as a nomogram. The predictive performance was assessed by receiver operating characteristic analysis. Survival analysis was conducted using the Kaplan-Meier method.

RESULTS: 165 patients were finally included, and 78 (47.27%) patients were grouped as high-HCC%. Four tumor habitats were determined. The fraction of habitat 1 (f1) was significantly higher, while the fraction of habitat 4 (f4) was significantly lower in the high-HCC% group than in the low-HCC% group. Tumor capsule, corona enhancement, delayed enhancement, f1, and f4 were used to construct the combined nomogram with AUCs of 0.927 and 0.923 in training and validation cohorts, respectively. The combined nomogram predicted-high-HCC% exhibited better prognoses than the predicted-low-HCC% groups in terms of recurrence-free survival and overall survival.

CONCLUSION: Enhancement-based CT habitat imaging exhibited potential for predicting the main component cHCC-CCA, and provided a tool for prognosis stratification.

KEY POINTS: Question The component of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) significantly affected the prognosis, but there is no effective method for predicting the main component of cHCC-CCA. Findings The combined nomogram integrated habitat parameters and radiological features can predict the main component of cHCC-CCA and help stratify the prognosis after hepatectomy. Clinical relevance The habitat-based combined nomogram offers an effective tool for personalized and appropriate treatment in cHCC-CCA patients.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Cai W, Zhu Y, Li D, et al. Intratumoral heterogeneity of CT enhancement for component prediction and prognostic significance in combined hepatocellular carcinoma‑cholangiocarcinoma. Eur Radiol. 2025. PMID: 41037071. doi:10.1007/s00330-025-12034-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。